EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Low-dose CT for MRI-free quantification of tau PET in Alzheimer’s disease: a multicentre, cross-sectional, comparison study

Guilherme Povala, Livia Amaral, Bruna Bellaver, Firoza Z Lussier, Pamela C L Ferreira, Douglas T Leffa, Guilherme Bauer-Negrini, Raphael de Luca E Tuma, Alvaro de Oliveira Franco, Cécile Tissot, Quentin Finn, João Pedro Ferrari-Souza und 12 weitere

The Lancet Medical Imaging & Theranostics · 2026-08 · 1 (1) · 100007

DOI: 10.1016/j.lanmit.2026.100007 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift The Lancet Medical Imaging & Theranostics, 2026-08. Verfasst von Guilherme Povala und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Carlos III Health Institute, Tatiana Pérez de Guzmán el Bueno Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tau PET quantification typically requires structural MRI for reference-region definition, normalisation, and segmentation. We evaluated whether low-dose CT can serve as a reliable MRI alternative for tau PET quantification when MRI is unavailable.

Methods

In this multicentre cross-sectional methods comparison study, we developed a PET-CT pipeline using low-dose CT as the sole anatomical reference for tau PET quantification. Participants were recruited from six sites in the multicentre Head-to-head Harmonisation of tau PET tracers (HEAD) study. The cohort comprised cognitively unimpaired (CU) young adults ( 65 years), and participants with mild cognitive impairment (MCI) or dementia. Participants underwent [18F]MK6240 and [18F]Flortaucipir PET-CT, T1-weighted MRI, and amyloid PET. SUVRs were calculated for three AD-relevant composite regions and 34 individual cortical regions using a template-based cerebellar reference and compared with PET-MR pipelines using template-based or FreeSurfer subject-space segmentation. Agreement was assessed using linear regression, intraclass correlation coefficients (ICC), Bland-Altman analysis, equivalence testing (two one-sided tests, TOST), and Cohen's kappa (κ) for binary positivity concordance.

Findings

A total of 387 participants were included, with recruitment spanning from November 11, 2022 and July 7, 2025 (205 [53%] female, 182 [47%] male; 6 [2%] aged 19-25 years, 130 [34%] aged 50-65 years and 251 [65%] aged 66-89 years). Against the template-based PET-MR pipeline, CT-derived SUVRs showed near-perfect linear correspondence with the template-based PET-MR pipeline for MK6240 (R2 0·959-0·975) and Flortaucipir (R2 0·925-0·964), with high absolute agreement (ICC 0·976-0·985 and 0·955-0·978, respectively). Against the FreeSurfer subject-space pipeline, correspondence remained strong for MK6240 (R2 0·952-0·971) and Flortaucipir (R2 0·909-0·949). Mean R2 across 34 cortical regions was 0·917 (SD 0·049) for MK6240 and 0·874 (SD 0·057) for Flortaucipir. Tau-positivity concordance was high (92·0-96·6%; κ 0·802-0·895; all p 0·05). Equivalence was formally confirmed by TOST (all p

Autor:innen und Institutionen

  • Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.
  • Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
  • Department of Neurology, Houston Methodist Research Institute and Weill Cornell Medicine, Houston, TX, USA.
  • Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Douglas Research Institute, Montréal, QC, Canada.
  • Sant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Edward and Pearl Fein Memory and Aging Center, University of California San Francisco, San Francisco, CA, USA.

Förderung

  • NIA NIH HHS
  • Carlos III Health Institute
  • Tatiana Pérez de Guzmán el Bueno Foundation
  • Alzheimer's Association
  • National Institutes of Health
  • Center for Networked Biomedical Research on Neurodegenerative Diseases
  • Weston Brain Institute
  • Canadian Institutes of Health Research

Zitieren

APA

Povala, G., Amaral, L., Bellaver, B., Lussier, F. Z., Ferreira, P. C. L., Leffa, D. T., Bauer-Negrini, G., de Luca E Tuma, R., de Oliveira Franco, A., Tissot, C., Finn, Q., Ferrari-Souza, J. P., Zimmer, E. R., Tudorascu, D. L., Masdeu, J. C., Fortea, J., Soleimani-Meigooni, D. N., Lowe, V., Oh, H., …, & Pascoal, T. A. (2026). Low-dose CT for MRI-free quantification of tau PET in Alzheimer’s disease: a multicentre, cross-sectional, comparison study. The Lancet Medical Imaging & Theranostics, 1(1), 100007. https://doi.org/10.1016/j.lanmit.2026.100007

Vancouver

Povala G, Amaral L, Bellaver B, Lussier FZ, Ferreira PCL, Leffa DT, et al. Low-dose CT for MRI-free quantification of tau PET in Alzheimer’s disease: a multicentre, cross-sectional, comparison study. The Lancet Medical Imaging & Theranostics. 2026;1(1):100007. doi:10.1016/j.lanmit.2026.100007

BibTeX
@article{Povala2026,
  author = {Povala, Guilherme and Amaral, Livia and Bellaver, Bruna and Lussier, Firoza Z and Ferreira, Pamela C L and Leffa, Douglas T and Bauer-Negrini, Guilherme and de Luca E Tuma, Raphael and de Oliveira Franco, Alvaro and Tissot, Cécile and Finn, Quentin and Ferrari-Souza, João Pedro and Zimmer, Eduardo R and Tudorascu, Dana L and Masdeu, Joseph C and Fortea, Juan and Soleimani-Meigooni, David N and Lowe, Val and Oh, Hwamee and Gordon, Brian A and Pascual, Belen and Rosa-Neto, Pedro and Baker, Suzanne and Pascoal, Tharick A},
  title = {Low-dose CT for MRI-free quantification of tau PET in Alzheimer’s disease: a multicentre, cross-sectional, comparison study},
  journal = {The Lancet Medical Imaging & Theranostics},
  year = {2026},
  volume = {1},
  number = {1},
  pages = {100007},
  doi = {10.1016/j.lanmit.2026.100007}
}
Kostenlos starten →